Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arcturus Therapeutics
Biotech
'Highly unlikely' BARDA will pull bird flu vax funding: Arcturus
Arcturus says it’s “highly unlikely” it will lose funding for its bird flu trial, despite rumors swirling that Moderna’s support will be revoked.
James Waldron
Mar 7, 2025 10:24am
Arcturus sa-mRNA COVID boosters induce immune response in ph. 2
Sep 19, 2023 11:40am
Valneva, Arcturus add to chorus of COVID-19 vax booster data
Dec 16, 2021 10:10am
The mRNA era after COVID-19: What's next in the pipeline
Sep 1, 2021 11:28am
Chutes & Ladders—Former Novartis oncology head jumps to startup
Jun 1, 2018 10:10am
In a twist, new Arcturus board restores old CEO
May 31, 2018 10:10am
